https://www.selleckchem.com/pr....oducts/asciminib-abl
Mean age was 51±20y and 53% were male. The rates of 6-month readmission, major complications, reoperation, and FTR increased significantly over the study period. The median hospital costs also increased over the study period (2012 $9600 to 2015 $13000; p3 comorbidities (β=-0.292 [-0.359 - (-0.21)], readmission to a different hospital (β=-0.755 [-0.914 - (-0.558)]), admission to low volume centers (β=-0.927 [-1.126 - (-0.682)]), lack of rehabilitation (β=-0.004[-0.005 - (-0.003)]), and admission on a weekend (β=-0.318 [-0.366 -
Curtir
Comentario
Compartilhar
